Skip to content
  • Sunday, 26 July 2026
  • 2:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Laboratory Automation & Robotics

Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma

Lana Keisha Jul 2, 2026 0

As Peter Gassner, CEO of Veeva Systems, the long-established cloud software provider dominating the life sciences industry, prepared to take…

Read More
Laboratory Automation & Robotics

Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma

Lana Keisha Jun 24, 2026 0

Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…

Read More
Laboratory Automation & Robotics

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Lana Keisha Jun 16, 2026 0

In a significant move underscoring the escalating competition in the life sciences technology sector, Salesforce announced that over 140 life…

Read More
Laboratory Automation & Robotics

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Lana Keisha Jun 2, 2026 0

In a strategic maneuver that underscores the intensifying competition in the life sciences technology sector, Salesforce has announced that over…

Read More
University of Toronto Study Reveals Mental Sharpness Fluctuations Account for Significant Daily Productivity GapsMSD Secures Landmark Approval for First Oral PCSK9 Inhibitor, Ushering in New Era for Cholesterol Management and Strategic DiversificationUniversity of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal TestingCornell University Engineers Develop Microscale Wireless Neural Implant Capable of Long-Term Brain Activity Monitoring and Data Transmission
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ